Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateHeureSourceTitreSymboleSociété
25/02/201117h00Business WireBioScrip to Host Fourth Quarter and Year-End 2010 Earnings CallNASDAQ:BIOSBioPlus Acquisition Corporation
14/02/201123h38Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:BIOSBioPlus Acquisition Corporation
03/02/201121h22Edgar (US Regulatory)Current report filing (8-K)NASDAQ:BIOSBioPlus Acquisition Corporation
01/02/201121h09Business WireEmerald Holds Annual Groundhog Day Investment ForumNASDAQ:BIOSBioPlus Acquisition Corporation
31/01/201122h32Business WireBioScrip Provides Update on Strategic Assessment to Improve Financial and Operational PerformanceNASDAQ:BIOSBioPlus Acquisition Corporation
31/01/201122h30Business WireMJ Graves Appointed Interim Chief Financial Officer of BioScripNASDAQ:BIOSBioPlus Acquisition Corporation
25/01/201116h29PR Newswire (US)Zacks Bull and Bear of the Day Highlights: OmniVision Technologies, BioScrip, McDonald, Halliburton and SchlumbergerNASDAQ:BIOSBioPlus Acquisition Corporation
24/01/201123h12Business WireBioScrip to Host Update Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
06/01/201122h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
30/12/201020h04Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:BIOSBioPlus Acquisition Corporation
28/12/201017h28Business WireBioScrip Completes Debt RefinancingNASDAQ:BIOSBioPlus Acquisition Corporation
03/12/201020h57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOSBioPlus Acquisition Corporation
01/12/201013h00Business WireBioScrip Appoints David W. Froesel, Jr. as Executive Vice President, Chief Financial Officer and TreasurerNASDAQ:BIOSBioPlus Acquisition Corporation
17/11/201023h06Business WireBioScrip, Inc. to Present at the 22nd Annual Piper Jaffray Health Care ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
09/11/201022h30Business WireBioScrip, Inc. to Present at Bank of America Merrill Lynch 2010 Credit ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
03/11/201021h16Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201011h01Business WireBioScrip Reports 2010 Third Quarter ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201011h00Business WireBioScrip Names Richard M. Smith as Chief Executive OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
18/10/201014h30Business WireBioScrip, Inc. to Host 2010 Third Quarter Earnings CallNASDAQ:BIOSBioPlus Acquisition Corporation
22/09/201020h04Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:BIOSBioPlus Acquisition Corporation
14/09/201014h30PR Newswire (US)Access Pharmaceuticals Receives Initial Purchase Order for MuGard in North AmericaNASDAQ:BIOSBioPlus Acquisition Corporation
13/09/201022h44Business WireBioScrip, Inc. to Present at Two Upcoming ConferencesNASDAQ:BIOSBioPlus Acquisition Corporation
29/07/201023h46Business WireBioScrip to Present at BMO Capital Markets 10th Annual Focus on Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
20/07/201014h30PR Newswire (US)Access Pharmaceuticals Signs Exclusive Specialty Distribution Agreement With BioScripNASDAQ:BIOSBioPlus Acquisition Corporation
15/07/201022h50Business WireBioScrip, Inc. to Host 2010 Second Quarter Earnings CallNASDAQ:BIOSBioPlus Acquisition Corporation
14/07/201012h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:BIOSBioPlus Acquisition Corporation
13/07/201018h45Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:BIOSBioPlus Acquisition Corporation
08/07/201022h00Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:BIOSBioPlus Acquisition Corporation
08/07/201021h04Edgar (US Regulatory)Registration Statement for securities to be issued in business combination transactions (S-4/A)NASDAQ:BIOSBioPlus Acquisition Corporation
22/06/201012h01Edgar (US Regulatory)Securities Registration: Business Combination (S-4)NASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS